DOCSLIB.ORG

Annual Review 2010

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Review 2010 Annual Review 2010 Wellcome Trust Annual Review 1 October 2009–30 September 2010 September 2009–30 October Annual1 Review Trust Wellcome Celebrating Highlights of the Wellcome Trust’s work in 2010 – a year that saw us celebrating a decade of discovery since the draft sequence of the human genome was unveiled. a decade Wellcome Trust We are a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the ofof discoverydiscovery medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests. www.wellcome.ac.uk Wellcome Trust Gibbs Building 215 Euston Road London NW1 2BE, UK T +44 (0)20 7611 8888 F +44 (0)20 7611 8545 E [email protected] www.wellcome.ac.uk The Wellcome Trust is a charity registered in England and Wales, no. 210183. Its sole trustee is The Wellcome Trust Limited, a company registered in England and Wales, no. 2711000 (whose registered office is at 215 Euston Road, London NW1 2BE, UK). FI-4936/9K/01-2011/AF We are grateful to the many researchers and members of ISBN 978 1 84129 089 8 Vision Wellcome Trust staff who helped to produce this volume, The Wellcome Trust is a charity registered in England everyone who agreed to be reviewed in this issue, and To achieve extraordinary improvements in and Wales, no. 210183. Its sole trustee is The Wellcome everyone who supplied images or gave us permission for Trust Limited, a company registered in England and human and animal health. their images to be used. Wales, no. 2711000 (whose registered office is at 215 Euston Road, London NW1 2BE, UK). Editor Mission Dr Giles Newton First published by the Wellcome Trust, 2011. To support the brightest minds in biomedical Assistant Editors © The trustee of the Wellcome Trust, London, and Tom Freeman, Kirsty Strawbridge licensed under Creative Commons Attribution 2.0 UK. research and the medical humanities. Writers This is an open access publication and, with the exception Penny Bailey of images and illustrations, the content may, unless Ailbhe Goodbody otherwise stated, be reproduced free of charge in any Mun-Keat Looi format or medium, subject to the following conditions: Executive Board Design content must be reproduced accurately; content must not Anja Fouad be used in a misleading context; and the Wellcome Trust must be attributed as the original author and the title of Mark Walport Photography the document specified in the attribution. Director of the Wellcome Trust David Sayer, Richard Hall Wellcome Trust Ted Bianco Project Manager Gibbs Building Director of Technology Transfer Lucy Moore 215 Euston Road Simon Jeffreys Publisher London NW1 2BE, UK Chief Operating Officer Hugh Blackbourn T +44 (0)20 7611 8888 David Lynn F +44 (0)20 7611 8242 Comments on the Wellcome Trust Annual Review Head of Strategic Planning and Policy E [email protected] are welcomed and should be sent to: Clare Matterson Hugh Blackbourn www.wellcome.ac.uk Director of Medical Humanities and Publishing Department Engagement Wellcome Trust Images are courtesy of Wellcome Images Gibbs Building (images.wellcome.ac.uk), except as follows: John Stewart 215 Euston Road Head of Legal and Company Secretary London NW1 2BE, UK Cover and page 26: Pasieka/Science Photo Library; page 6: Danny Truell Justin Piperger Photography/Wadsworth 3d; Garry F +44 (0)20 7611 8270 Chief Investment Officer Delong/Science Photo Library; page 9: L V Prasad Eye E [email protected] Institute; page 12: Araminta de Clermont/Michael Hoppen Position vacant Gallery; page 17: Anne Weston, LRI, CRUK/Wellcome Director of Science Funding The Wellcome Trust Annual Review is distributed via a Images; page 18: Dr Peter Campbell from Nature 463, mailing list held by the Wellcome Trust. If you would like As at January 2011 184–190; page 21: Dr David Furness/Wellcome Images; to be added to the list, or if you have a colleague who page 23: Peter Vercellino/iStockphoto; page 24: Spike would like to receive the Wellcome Trust Annual Review, Walker/Wellcome Images; page 27: A J Irving/Wellcome please contact: Images; page 30: Gull Lab, Sir William Dunn School of Board of Governors Publishing Department Pathology/Wellcome Images; page 32: Mark Jones/ Wellcome Trust Wellcome Images; page 33: Profesor Gabriel Waksman; William Castell, Chairman Freepost RSHU-ZJKL-LCZK page 34: MRC Human Genetics Unit/Wellcome Images; Peter Rigby, Deputy Chairman Feltham TW14 0RN page 37: Gordon Museum/Wellcome Images; page 38, 40: Kay Davies Annie Cavanagh/Wellcome Images. Peter Davies T +44 (0)20 7611 8651 Christopher Fairburn F +44 (0)20 7611 8242 Cover image: Computer artwork of a chromosome. Richard Hynes E [email protected] Anne Johnson www.wellcome.ac.uk/publications Roderick Kent Eliza Manningham-Buller Peter Smith As at January 2011 Contents Director’s statement 2 Supporting outstanding researchers 4 Accelerating the application of research 8 Exploring medicine in historical and cultural contexts 12 Maximising the health benefits of genetics and genomics 16 Understanding the brain 22 Combating infectious disease 28 Investigating development, ageing and chronic disease 34 Connecting environment, nutrition and health 38 Investment and expenditure 42 Operational excellence 44 Communications 46 Advisory committees 2009/10 48 Annual Review 2010 | 1 Director’s statement This year, we celebrated the tenth anniversary of the first draft of the human genome and, with the publication of our new Strategic Plan, looked forward to the decade ahead. In 2000, Tony Blair and Bill Clinton announced the understanding of the links between genes and health. completion of the draft sequence of the human genome. Hence, this year, we launched major projects to study the This was a milestone in biology and medicine. The genomes of 10 000 people in the UK (UK10K) and Human Genome Project brought together thousands of thousands of people in Africa (the Human Heredity and scientists from six countries to master the technical Health in Africa Project, or H3 Africa). The UK10K project challenge of lining up 3 billion bases of DNA into the aims to apply whole genome sequencing to find many genome sequence. We took the lead in ensuring that all uncommon or rare genetic variants that are important in of these data were freely available on the internet. This human disease. H3 Africa, a partnership with the US approach has enabled scientists worldwide to use the National Institutes of Health to fund scientists working in reference sequence in their studies of almost every aspect Africa, will help us to understand how genes and the of human biology. environment interact in the development of diseases such as cancer, heart disease and malaria. A decade later, we have seen remarkable progress in deciphering and understanding the content of the We take a long-term view to funding research, allowing genome. We are learning how our genome compares the researchers that we support to tackle difficult and with those of other species, how genes are expressed ambitious questions. This is evident in our new Strategic and regulated, and about the functions of the RNA Plan for 2010–20: Extraordinary Opportunities, which was and proteins that it encodes. Equally important are launched in February 2010. The Plan set outs our three collaborations between geneticists and clinicians that are areas of focus for the next decade: supporting outstanding discovering how inherited and acquired differences in researchers, accelerating the application of research, and DNA sequence influence human variation in health and exploring medicine in historical and cultural contexts. It disease. Leading the way in this latter field of research are also poses five research challenges: maximising the health genome-wide association studies – notably the Wellcome benefits of genetics and genomics; understanding the Trust Case Control Consortium – that are uncovering the brain; combating infectious diseases; investigating myriad genetic variants that influence our susceptibility development, ageing and chronic disease; and connecting to many common diseases. Such research would not be environment, nutrition and health. Each challenge has possible without the remarkable technological many research questions and brings together the many innovations that have enabled a phenomenal increase in different activities of the Trust – including research in our ability to sequence DNA. The first genome took ten biology and medicine, the translation of research into years to produce and cost approximately £700 million; healthcare products, public engagement, the history of today, the Wellcome Trust Sanger Institute can sequence medicine and the ethics of research. the equivalent of two genomes each day at a fraction of the cost. There is every expectation that the price of How can we ensure that we make progress as effectively sequencing will continue to reduce dramatically as as possible in these challenges? The key is to fund the technology advances. best researchers, so we have launched a new scheme – Wellcome Trust Investigator Awards – that extends the Despite this progress, there is still much to discover. We ethos of our highly successful fellowship schemes to still do not know the full extent of the variation in the researchers who are in established posts. human genome, some of which is common and found in many millions of individuals, and some of which is rare We also want to make sure that researchers have the best and found in only a tiny fraction of the world’s population. facilities and equipment. The flagship new project for UK And we are only a small part of the way towards an science is the UK Centre for Medical Research and 2 | Annual Review 2010 Innovation (UKCMRI) in London, which is expected to based on the discovery of mutations in a growth factor open in 2015.
Load more

Recommended publications
  • ANNUAL REVIEW 1 October 2005–30 September
    WELLCOME TRUST ANNUAL REVIEW 1 October 2005–30 September 2006 ANNUAL REVIEW 2006 The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. It funds innovative biomedical research, in the UK and internationally, spending around £500 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research and its impact on health and wellbeing. www.wellcome.ac.uk THE WELLCOME TRUST The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. 123 CONTENTS BOARD OF GOVERNORS 2 Director’s statement William Castell 4 Advancing knowledge Chairman 16 Using knowledge Martin Bobrow Deputy Chairman 24 Engaging society Adrian Bird 30 Developing people Leszek Borysiewicz 36 Facilitating research Patricia Hodgson 40 Developing our organisation Richard Hynes 41 Wellcome Trust 2005/06 Ronald Plasterk 42 Financial summary 2005/06 Alastair Ross Goobey 44 Funding developments 2005/06 Peter Smith 46 Streams funding 2005/06 Jean Thomas 48 Technology Transfer Edward Walker-Arnott 49 Wellcome Trust Genome Campus As at January 2007 50 Public Engagement 51 Library and information resources 52 Advisory committees Images 1 Surface of the gut. 3 Zebrafish. 5 Cells in a developing This Annual Review covers the 2 Young children in 4 A scene from Y fruit fly. Wellcome Trust’s financial year, from Kenya. Touring’s Every Breath. 6 Data management at the Sanger Institute. 1 October 2005 to 30 September 2006. CONTENTS 1 45 6 EXECUTIVE BOARD MAKING A DIFFERENCE Developing people: To foster a Mark Walport The Wellcome Trust’s mission is research community and individual Director to foster and promote research with researchers who can contribute to the advancement and use of knowledge Ted Bianco the aim of improving human and Director of Technology Transfer animal health.
    [Show full text]
  • Vol 9 No 1 Spring
    A PUBLICATION OF THE AMERICAN SOCIETY FOR MATRIX BIOLOGY SPRING 2010, VOLUME 9, NO. 1 President’s Letter Expanding the Society’s Value to You and Your Role in the Society Since its inception in 2001, the principal function of the ASMB has been to organize the OFFICERS biennial meeting. The value of this meeting to our members cannot be understated. The ASMB meeting has emerged as the matrix-centric President: meeting in North America, and it provides an William Parks (2010) open venue for students, postdocs, fellows, and junior faculty to present their work and to inter- act with established investigators. Speaking for Vice Pres/President Elect myself, I very much look forward to the ASMB Jean Schwarzbauer (2010) meeting, not only because I get to see many Bill Parks friends, but also to hear a lot of incredibly good science. This year’s meeting will be no excep- Past President: tion and promises to be truly outstanding. I applaud Jean Schwarzbauer and the Renato Iozzo (2010) rest of the Program Committee for putting together an exciting meeting loaded with interesting topics and great speakers (please check out the program here). By organizing the meeting, ASMB provides value to you, the membership, but I Secretary/Treasurer think we–the Society–should always be looking to do more; that is, to provide more Joanne Murphy-Ullrich (2011) bang for your dues buck. For this year’s meeting, we have expanded the Travel Awards that will be given to trainees in recognition of outstanding research, and we recently established merit-based Minority Scholarships that will be awarded to eli- Council Members gible students and postdocs.
    [Show full text]
  • SAC 2014 Celebration of Science Book
    Fostering Innovation at MGH Poster Session Abstracts 67th Annual Meeting of the MGH Scientific Advisory Committee Celebration of Science The MGH Research Institute: Meeting the Challenges that Lie Ahead April 2 & 3, 2014 Simches Auditorium 185 Cambridge Street, 3rd Floor Management Management ECOR Administrative Offices | 50 Staniford Street, 10th Floor | Boston, MA 02114 | [email protected] Fostering Mainstay Mainstay Innovation of MGH of MGH at MGH Management Innovation Management Innovation Welcome elcome to the 67th Annual Meeting of the MGH Scientific Advisory Committee (SAC) on April 2nd and 3rd, 2014. Dr. Richard Lifton has graciously agreed to W chair our SAC meeting again this year. As in past years, we will begin our two-day SAC meeting with a Celebration of Science at MGH. Our poster session begins at 11:00 am on Wednesday, April 2, followed by an afternoon Research Symposium from 2:00 pm to 5:00 pm. The outstanding MGH researchers who will be presenting their work in our Symposium this year are the 2014 Howard Goodman Award recipient Filip Swirski, PhD and the 2014 Martin Basic and Clinical Research Prize recipients, Jayaraj Rajagopal, MD, and Stephanie Seminara, MD. We are honored to have as our keynote speaker, Richard O. Hynes, PhD, from MIT. We will close the first day with a Reception for invited guests at the Russell Museum. On Thursday, April 3, Dr. Kingston will open the SAC meeting with an ECOR Report. After this report, Anne Klibanski, MD, Partners Chief Academic Officer, will give a presentation on the Integration of MGH Research to the Partners Enterprise.
    [Show full text]
  • Hhmi Bulletin 3 4 Hhmi Club
    HHMI BULLETIN 4000 Jones Bridge Road • Chevy Chase, Maryland 20815-6789 Howard Hughes Medical Institute www.hhmi.org One Lump or Two? in this issue Once again, those fast-growing yeast find a way to turn a The Silicon Marvel long-held theory on its head. This time, it’s about prions, • Prions for Good which aren’t as universally nasty as once suspected. Some may actually help organisms evolve. The yeast colony shown here www.hhmi.org A Kaleidoscopic View contains a protein in its prion form. Because the prion, known as PSI+, is self-replicating and forms fibrous amyloids, the yeast look lumpy and bumpy—strikingly different from normally smooth yeast. Susan Lindquist’s group has found 19 yeast proteins that can switch back and forth between a normal and a prion version. The prions are thought to help the yeast adapt to changing conditions (see “A Silver Lining,” page 22). LIGHT MOVES v ol. 23 Heather True / Lindquist lab /no. 02 O b s e r v a t i O n s 16 Secret Agent MAn Skin cells do more than just cover our bodies. As a neurology resident, Stanley Prusiner saw Creutzfeldt–Jakob agent began to emerge. These data established, for the first time, that Keratinocytes, for example, anchor immune cells disease kill a patient in a matter of months. Researchers knew the rare a particular macromolecule was required for infectivity and that this within the epidermis, move and proliferate during neurodegenerative disease and scrapie, a similar disease in sheep, macromolecule was a protein …. wound healing, and even secrete inhibitory molecules were infectious but not as a result of a typical virus.
    [Show full text]
  • Summarised Financial Statements 2012
    Summarised Financial Statements 2012 Contents Chairman’s Statement 02 02 Summary Trustee’s Report 04 04 Vision and Objects, Mission, Focus Areas 04 and Challenges Financial Review 06 Extracts from the Review of Investment Activities 08 Independent Auditors’ Report 10 10 Consolidated Statement of Financial Activities 11 Consolidated Balance Sheet 12 Consolidated Cash Flow Statement 13 Grants Awarded 14 Reference and Administrative Details 16 Chairman’s Statement Sustained investment in research can bring real benefits or Medicine which was shared by a dozens of genomes every day. Their former Governor of the Trust, work is driving the first wave of Professor Sir John Gurdon. His work stratified medicine, improving cancer showed that mature cells had the therapy for patients by examining the potential to be reprogrammed into genetics of individual tumours, and stem cells. Subsequent decades of revealing the genetic basis of the way investment in stem cell research have specific cancers respond to different brought us ever closer to realising the drugs. promise of stem cell therapies. At the same time, ever-improving We saw again this year how sustained technology is giving us an advantage investment in research can bring real against infectious diseases. A study benefits. Genetics has been one of the published this summer demonstrated Trust’s most focused areas of funding how modern genome sequencing Summary of Chairman’s since the mid-1990s. First, we sought could track methicillin-resistant Statement to decode the human genome; then Staphylococcus aureus (MRSA). we had to find ways to apply that Retrospective analysis of samples • We committed £701 million in grant knowledge.
    [Show full text]
  • February 7, 2007 (Download PDF)
    Volume 51 – Number 16 Wednesday – February 7, 2007 TechTalk S ERVING T HE M I T C OMMUNITY Reactivated gene shrinks tumors, MIT study finds Anne Trafton cancer treatments,” said David Kirsch of known whether such activity would actu- properly, it activates DNA repair mecha- News Office MIT’s Center for Cancer Research and ally reverse tumor growth in primary nisms and prevents cells with damaged Harvard Medical School, one of the lead tumors. DNA from dividing. If DNA damage is co-authors of the paper. The new MIT study shows that re-acti- irreparable, p53 induces the cell to destroy Many cancers arise due to defects in The study appeared in the Jan. 25 vating p53 in mouse tumors dramatically itself by undergoing apoptosis, or pro- genes that normally suppress tumor issue of Nature. It was conducted in the reduces the size of the tumors, in some grammed cell death. growth. Now, for the first time, MIT laboratory of Tyler Jacks, director of the cases by 100 percent. When p53 is turned off by mutation researchers have shown that re-activat- Center for Cancer Research, the David H. “This study provides critical genetic or deletion, cells are much more likely ing one of those genes in mice can cause Koch Professor of Biology and a Howard evidence that continuous repression of a to become cancerous, because they will tumors to shrink or disappear. Hughes Medical Institute investigator. tumor suppressor gene is required for a divide uncontrollably even when DNA is The study offers evidence that the P53 has long been known to play a tumor to survive,” said Andrea Ventura, an damaged.
    [Show full text]
  • Elliot Levey
    Elliot Levey Agents Ruth Young Associate Agent Phoebe Trousdell [email protected] +44 (0)20 3214 0800 Assistant Lauren Morgan [email protected] +44 (0)20 3214 0800 Assistant Alex Campbell [email protected] +44 (0)20 3214 0800 Roles Film Production Character Director Company MURDER ON THE Rabbi Kenneth Branagh Twentieth Century Fox ORIENT EXPRESS DENIAL Roger Levey Mick Jackson Krasnoff / Foster Entertainment FALLEN Dr. Watkins Scott Hicks Lotus Entertainment/ Mayhem Pictures THE MASTER OF YORK Menachem Kieron Quirke Eagle Lion Monster Films FLORENCE FOSTER Edgar Booth Stephen Frears Florence Film Ltd JENKINS Cunningham Jr United Agents | 12-26 Lexington Street London W1F OLE | T +44 (0) 20 3214 0800 | F +44 (0) 20 3214 0801 | E [email protected] Production Character Director Company THE LADY IN THE VAN Director Nicholas Hytner Van Production Ltd. SPOOKS Philip Emmerson Bharat Nalluri Shine Pictures & Kudos PHILOMENA Alex Stephen Frears Lost Child Limited THE WALL Stephen Cam Christiansen National film Board of Canada THE QUEEN Stephen Frears Granada FILTH AND WISDOM Madonna HSI London SONG OF SONGS Isaac Josh Appignanesi AN HOUR IN PARADISE Benjamin Jan Schutte BOOK OF JOHN Nathanael Philip Saville DOMINOES Ben Mirko Seculic JUDAS AND JESUS Eliakim Charles Carner Paramount QUEUES AND PEE Ben Despina Catselli Pinhead Films JASON AND THE Canthus Nick Willing Hallmark ARGONAUTS JESUS Tax Collector Roger Young Andromeda Prods DENIAL Roger Levey Denial LTD Television Production Character Director Company
    [Show full text]
  • 2019: the Year in Experimental Medicine Why Submit to Jem?
    2019: THE YEAR IN EXPERIMENTAL MEDICINE WHY SUBMIT TO JEM? FORMAT NEUTRAL You may submit your papers in ANY format. 92% OF INVITED REVISIONS ARE ACCEPTED TRANSFER POLICY We welcome submissions that include reviewer comments from another journal. You may also request manuscript transfer between Rockefeller University Press journals, and we can confidentially send reviewer reports and identities to another journal beyond RUP. INITIAL DECISION IN 6 DAYS FAIR AND FAST We limit rounds of revision, and we strive to provide clear, detailed decisions that illustrate what is expected in the revisions. Articles appear online one to two days after author proofs are returned. TIME IN PEER REVIEW 38 DAYS OPEN ACCESS OPTIONS Our options include Immediate Open Access (CC-BY) and open access six months after publication (CC-BY-NC-SA). *Median 2019 An Editorial Process Guided by Your Community At JEM, all editorial decisions on research manuscripts are made through collaborative consultation between professional scientific editors and the academic editorial board. Submission or transfer Academic and scientific If appropriate, sent Academic and scientific Informed decisions editors review to Peer Review editors review comments sent to authors Revised manuscript Academic and scientific 92% of invited Published online Circulated via alerts and submission and rereview editors review revisions accepted* 1-2 days after author social media to readers proofs returned around the world 2019: THE YEAR IN EXPERIMENTAL MEDICINE t the beginning of 2020, the start of a new decade, the Journal of Experimental Medicine (JEM) is proud to present our annual Year in Experimental Medicine collection to highlight some of the articles that were of greatest interest to our readers last year.
    [Show full text]
  • The Old-Timer
    The Old-Timer produced by www.prewarboxing.co.uk Number 1. August 2007 Sid Shields (Glasgow) – active 1911-22 This is the first issue of magazine will concentrate draw equally heavily on this The Old-Timer and it is my instead upon the lesser material in The Old-Timer. intention to produce three lights, the fighters who or four such issues per year. were idols and heroes My prewarboxing website The main purpose of the within the towns and cities was launched in 2003 and magazine is to present that produced them and who since that date I have historical information about were the backbone of the directly helped over one the many thousands of sport but who are now hundred families to learn professional boxers who almost completely more about their boxing were active between 1900 forgotten. There are many ancestors and frequently and 1950. The great thousands of these men and they have helped me to majority of these boxers are if I can do something to learn a lot more about the now dead and I would like preserve the memory of a personal lives of these to do something to ensure few of them then this boxers. One of the most that they, and their magazine will be useful aspects of this exploits, are not forgotten. worthwhile. magazine will be to I hope that in doing so I amalgamate boxing history will produce an interesting By far the most valuable with family history so that and informative magazine. resource available to the the articles and features The Old-Timer will draw modern boxing historian is contained within are made heavily on the many Boxing News magazine more interesting.
    [Show full text]
  • Do Androids Dream of Computer Music? Proceedings of the Australasian Computer Music Conference 2017
    Do Androids Dream of Computer Music? Proceedings of the Australasian Computer Music Conference 2017 Hosted by Elder Conservatorium of Music, The University of Adelaide. September 28th to October 1st, 2017 Proceedings of the Australasian Computer Music Conference 2017, Adelaide, South Australia Keynote Speaker: Professor Takashi Ikegami Published by The Australasian University of Tokyo Computer Music Association Paper & Performances Jury: http://acma.asn.au Stephen Barrass September 2017 Warren Burt Paul Doornbusch ISSN 1448-7780 Luke Dollman Luke Harrald Christian Haines All copyright remains with the authors. Cat Hope Robert Sazdov Sebastian Tomczak Proceedings edited by Luke Harrald & Lindsay Vickery Barnabas Smith. Ian Whalley Stephen Whittington All correspondence with authors should be Organising Committee: sent directly to the authors. Stephen Whittington (chair) General correspondence for ACMA should Michael Ellingford be sent to [email protected] Christian Haines Luke Harrald Sue Hawksley The paper refereeing process is conducted Daniel Pitman according to the specifications of the Sebastian Tomczak Australian Government for the collection of Higher Education research data, and fully refereed papers therefore meet Concert / Technical Support Australian Government requirements for fully-refereed research papers. Daniel Pitman Michael Ellingford Martin Victory With special thanks to: Elder Conservatorium of Music; Elder Hall; Sud de Frank; & OzAsia Festival. DO ANDROIDS DREAM OF COMPUTER MUSIC? COMPUTER MUSIC IN THE AGE OF MACHINE
    [Show full text]
  • MSU Commencement Ceremonies Fall 2020
    COMMENCEMENT CEREMONIES FALL 2020 “Go forth with Spartan pride and confdence, and never lose the love for learning and the drive to make a diference that brought you to MSU.” Samuel L. Stanley Jr., M.D. President Michigan State University Photo above: an MSU entrance marker of brick and limestone, displaying our proud history as the nation’s pioneer land-grant university. On this—and other markers—is a band of alternating samara and acorns derived from maple and oak trees commonly found on campus. This pattern is repeated on the University Mace (see page 10). Inside Cover: Pattern of alternating samara and acorns. Michigan State University photos provided by University Communications. ENVIRONMENTAL TABLE OF CONTENTS STEWARDSHIP Mock Diplomas and the COMMENCEMENT Commencement Program Booklet 3 Virtual Commencement Ceremonies Commencement mock diplomas, 4 The Michigan State University Board of Trustees which are presented to degree 5 Michigan State University Mission Statement candidates at their commencement 6–8 Congratulatory Letters from the President, Provost, and Executive Vice President ceremonies, are 30% post-consumer 9 Michigan State University recycled content. The Commencement 10 Ceremony Lyrics program booklet is 100% post- 11 University Mace consumer recycled content. 12 Academic Attire 13 Keynote Speakers Caps and Gowns 14–16 Keynote Speaker Profles Graduating seniors’ caps and gowns and master’s degrees’ caps and BACCALAUREATE DEGREES gowns are made of post-consumer 18 Honors recycled content; each cap and 19 Order of Ceremonies gown is made of a minimum of 20–21 College of Agriculture and Natural Resources 23 plastic bottles. 22 Residential College in the Arts and Humanities 23–24 College of Arts and Letters Recycle Your Cap and Gown 25–26 The Eli Broad College of Business Once all of your favorite photos are 27–29 College of Communication Arts and Sciences taken on campus, please recycle 30 College of Education your gown at the MSU Union 31–32 College of Engineering Spartan Spirit Shop.
    [Show full text]
  • Declan Conlon
    DECLAN CONLON Height: 6’ Eyes: Grey / Green Hair: Black FILM includes: director WE OURSELVES Paul Mercier WOP DAC SACRIFICE Peter Dowling SFP MY NAME IS EMILY Simon Fitzmaurice Hurricane Films DEBRIS Mark O Rowe Parallel Films LOVE ETERNAL Brendan Muldowney Fastnet Films CALVARY John McDonagh Bruno Films HEREAFTER Clint Eastwood Warner Bros BASKET CASE Owen O’Neil Blinder Films HONEST David A Stewart Honest Prods THE TROUBLE WITH SEX Fintan Connelly Fubar Films ALL SOULS DAY Alan Gilsenan Yellow Asylum Films ROMAN SPRING OF MRS STONE Robert Ackerman HBO TELEVISION includes IRISH CRIME STORY Zuli Aladay Cairde Films COUNSEL Declan Recks Lacada THE BAILOUT Conall Morrison Whitefriar Films VIKINGS IV Ken Girotti VK Prods INSPECTOR JURY Florian Kern IJ Prods AMBER Thaddeus O’Sullivan RTE RAW Various Ecossse / RTE FAIR CITY Various RTE SINGLE HANDED Various Touchpaper / RTE TROUBLE IN PARADISE Various Great Western / RTE HIDE AND SEEK Dearbhla Walsh Accomplice PROOF Ciaran Donnelly Subotica / RTE THE TUDORS Steve Shill Showtime BACHELORS WALK John Carney RTE / BBC HOT HOUSE Cilla Ware Channel 4 DANGERFIELD Laurence Gordon Clark BBC THE FAMILY Michael Winterbottom BBC Cont.. 24 Adelaide Street, Dun Laoghaire, Co. Dublin T: 1 663 8646 www.macfarlane-chard.ie Registered in Ireland Co No: 422112I VAT no: IE 6442112F. Registered under the Data Protection Act Registered Office: 32 Upper Mount Street, Dublin 2 Page 2 DECLAN CONLON THEATRE IRELAND includes Brian in COME ON HOME Rachel O’Riordan Peacock Theatre Turlough in NORA Eoghan Carrick Corn
    [Show full text]